Metoprolol succinate product
Reason category: Dissolution failure
FDA recall number D-0547-2026
Blood pressure / heart
Metoprolol succinate ER 50 mg
Public data on metoprolol from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
$0.0494
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-51%
change over five years
peak $0.3928 in 2014-01
28
approved generic applications (ANDAs) on record for Metoprolol Succinate
18 with a product still marketed · first 2006
Not listed
in FDA's current shortage list
Metoprolol Succinate Tablet, Extended Release: To Be Discontinued
NADAC per unit, monthly
METOPROLOL SUCC ER 50 MG TABShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.37199 |
| 2014-02 | 0.35645 |
| 2014-05 | 0.32843 |
| 2014-08 | 0.33222 |
| 2014-11 | 0.31393 |
| 2015-02 | 0.31250 |
| 2015-05 | 0.29941 |
| 2015-08 | 0.28389 |
| 2015-11 | 0.26223 |
| 2016-02 | 0.26367 |
| 2016-05 | 0.26223 |
| 2016-08 | 0.27639 |
| 2016-11 | 0.26270 |
| 2017-02 | 0.25314 |
| 2017-05 | 0.22962 |
| 2017-08 | 0.22443 |
| 2017-11 | 0.21817 |
| 2018-02 | 0.19798 |
| 2018-05 | 0.18707 |
| 2018-08 | 0.18988 |
| 2018-11 | 0.16142 |
| 2019-02 | 0.15344 |
| 2019-05 | 0.15114 |
| 2019-08 | 0.15759 |
| 2019-11 | 0.15998 |
| 2020-02 | 0.15826 |
| 2020-05 | 0.12832 |
| 2020-08 | 0.11724 |
| 2020-11 | 0.12094 |
| 2021-02 | 0.11128 |
| 2021-05 | 0.10672 |
| 2021-08 | 0.11347 |
| 2021-11 | 0.10143 |
| 2022-02 | 0.10220 |
| 2022-05 | 0.09652 |
| 2022-08 | 0.09012 |
| 2022-11 | 0.08874 |
| 2023-02 | 0.07584 |
| 2023-05 | 0.07702 |
| 2023-08 | 0.07983 |
| 2023-11 | 0.07734 |
| 2024-02 | 0.07616 |
| 2024-05 | 0.05700 |
| 2024-08 | 0.06048 |
| 2024-11 | 0.05897 |
| 2025-02 | 0.05873 |
| 2025-05 | 0.06540 |
| 2025-08 | 0.06696 |
| 2025-11 | 0.06473 |
| 2026-02 | 0.05774 |
| 2026-05 | 0.05322 |
| 2026-08 | 0.05790 |
| 2026-11 | 0.04940 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning metoprolol
openFDA enforcement records, by year reported.
| 2026 | 5 |
| 2025 | 1 |
| 2024 | 1 |
| 2023 | 4 |
| 2022 | 2 |
| 2018 | 2 |
| 2015 | 4 |
| 2014 | 8 |
27 records since 2012. A record is one product or lot, not one recall event. Combination products that contain metoprolol are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Metoprolol succinate extended-release tablets
Reason category: Dissolution failure
FDA recall number D-0355-2026
Metoprolol succinate extended-release tablets
Reason category: Dissolution failure
FDA recall number D-0357-2026
Metoprolol succinate extended-release tablets
Reason category: Dissolution failure
FDA recall number D-0354-2026
Metoprolol succinate extended-release tablets
Reason category: Dissolution failure
FDA recall number D-0356-2026
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention metoprolol
15 GxRadar articles cite or discuss this drug.
Generic or brand · Explainer · 6 min
Extended-release, delayed-release and immediate-release pills, and how FDA judges their generics
ER, XL, DR and the rest describe how a pill lets go of its drug. What the formulations are, how FDA tests generic copies of each, what the Orange Book codes say, and what our recall data show.
Price histories · Data story · 5 min
What pharmacies pay for seven blood pressure generics, 2014 and 2026
At federal survey rates, 365 tablets each of seven common blood pressure generics cost pharmacies about $95 in October 2026, down from $1,403 in October 2014. One drug explains most of the drop.
Price histories · Data story · 5 min
What pharmacies pay for a month of common generics
Thirty tablets of each of the 10 most-used generics we track cost pharmacies $35.70 in January 2014 and $8.80 in October 2026. That is acquisition cost, and the rest of the price sits on top of it.
Using medicines safely · Explainer · 6 min
Scored tablets and what the label says about them
Since 2013, FDA has reserved the phrase "functional scoring" for tablets tested to split evenly. Where that wording appears on a prescription label, what sits behind it, and how often it shows up in FDA's data.
Equivalence & alternatives · Explainer · 6 min
The 505(b)(2) pathway, between brand and generic
How FDA's hybrid new drug application works, how it differs from a full NDA and a generic ANDA, and what three years of approval data show about who uses it.
Manufacturing quality · Explainer · 6 min
Dissolution testing, the lab check behind many tablet recalls
How a dissolution test measures whether a pill releases its drug, how USP and FDA set the pass mark, and what 414 recall records citing dissolution show about which products fail.